Cwm LLC Has $2.51 Million Holdings in Align Technology, Inc. $ALGN

Key Points

• Cwm LLC increased its holdings in Align Technology, Inc. by 43.7% during the second quarter, bringing their total investment to approximately $2.51 million.
• Several institutional investors, including Wealth Enhancement Advisory Services and Janney Montgomery Scott, have also increased their positions in Align Technology during the first quarter of the year, contributing to a total institutional ownership of 88.43%.
• Align Technology's CEO, Joseph M. Hogan, purchased 7,576 shares at an average price of $131.49, representing a significant personal investment in the company.

Cwm LLC grew its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 43.7% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 13,271 shares of the medical equipment provider's stock after purchasing an additional 4,034 shares during the period. Cwm LLC's holdings in Align Technology were worth $2,513,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently made changes to their positions in ALGN. Wealth Enhancement Advisory Services LLC grew its position in shares of Align Technology by 44.3% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 9,380 shares of the medical equipment provider's stock worth $1,490,000 after purchasing an additional 2,881 shares in the last quarter. Exchange Traded Concepts LLC lifted its holdings in shares of Align Technology by 27.7% during the 1st quarter. Exchange Traded Concepts LLC now owns 4,929 shares of the medical equipment provider's stock worth $783,000 after acquiring an additional 1,068 shares during the period. Janney Montgomery Scott LLC lifted its holdings in shares of Align Technology by 48.9% during the 1st quarter. Janney Montgomery Scott LLC now owns 10,120 shares of the medical equipment provider's stock worth $1,608,000 after acquiring an additional 3,325 shares during the period. State of Alaska Department of Revenue lifted its holdings in shares of Align Technology by 2.7% during the 1st quarter. State of Alaska Department of Revenue now owns 8,220 shares of the medical equipment provider's stock worth $1,305,000 after acquiring an additional 215 shares during the period. Finally, North Growth Management Ltd. lifted its holdings in shares of Align Technology by 3.1% during the 1st quarter. North Growth Management Ltd. now owns 33,000 shares of the medical equipment provider's stock worth $5,175,000 after acquiring an additional 1,000 shares during the period. Institutional investors and hedge funds own 88.43% of the company's stock.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on ALGN. Weiss Ratings downgraded shares of Align Technology from a "hold (c-)" rating to a "sell (d+)" rating in a report on Wednesday, October 8th. Wells Fargo & Company cut their price target on shares of Align Technology from $246.00 to $199.00 and set an "overweight" rating for the company in a report on Thursday, July 31st. Mizuho cut their price target on shares of Align Technology from $210.00 to $170.00 and set an "outperform" rating for the company in a report on Monday, October 13th. Zacks Research raised shares of Align Technology from a "strong sell" rating to a "hold" rating in a report on Tuesday, September 30th. Finally, UBS Group cut their price target on shares of Align Technology from $160.00 to $155.00 and set a "neutral" rating for the company in a report on Thursday. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, Align Technology has an average rating of "Hold" and a consensus target price of $182.67.

Insider Buying and Selling

In other Align Technology news, CEO Joseph M. Hogan purchased 7,576 shares of the company's stock in a transaction dated Friday, August 1st. The stock was purchased at an average price of $131.49 per share, with a total value of $996,168.24. Following the completion of the purchase, the chief executive officer owned 184,945 shares of the company's stock, valued at approximately $24,318,418.05. The trade was a 4.27% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. 0.66% of the stock is currently owned by insiders.

Align Technology Price Performance

Shares of NASDAQ:ALGN opened at $130.45 on Friday. The company has a market cap of $9.46 billion, a price-to-earnings ratio of 22.00, a PEG ratio of 1.48 and a beta of 1.70. The firm has a 50 day simple moving average of $134.71 and a 200 day simple moving average of $163.30. Align Technology, Inc. has a one year low of $122.00 and a one year high of $246.19.

Align Technology (NASDAQ:ALGN - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The medical equipment provider reported $2.49 EPS for the quarter, missing the consensus estimate of $2.57 by ($0.08). The company had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $1.06 billion. Align Technology had a net margin of 11.04% and a return on equity of 13.36%. Align Technology's revenue for the quarter was down 1.6% on a year-over-year basis. During the same period in the previous year, the company earned $2.41 EPS. Align Technology has set its Q3 2025 guidance at EPS. As a group, analysts expect that Align Technology, Inc. will post 7.98 EPS for the current year.

Align Technology declared that its board has initiated a stock buyback plan on Tuesday, August 5th that allows the company to buyback $200.00 million in shares. This buyback authorization allows the medical equipment provider to reacquire up to 2% of its shares through open market purchases. Shares buyback plans are typically a sign that the company's board believes its shares are undervalued.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.